WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012115772) THERAPY FOR KIDNEY DISEASE AND/OR HEART FAILURE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/115772    International Application No.:    PCT/US2012/024207
Publication Date: 30.08.2012 International Filing Date: 07.02.2012
IPC:
A61K 9/08 (2006.01), A61K 38/22 (2006.01)
Applicants: MEDTRONIC, INC. [US/US]; 710 Medtronic Parkway, N.E. Minneapolis, MN 55432 (US) (For All Designated States Except US).
VAN ANTWERP, William [US/US]; (US) (For US Only).
WALSH, Andrew, J., L. [US/US]; (US) (For US Only).
MANDA, Venkatesh, R. [US/US]; (US) (For US Only).
BURNES, John [US/US]; (US) (For US Only)
Inventors: VAN ANTWERP, William; (US).
WALSH, Andrew, J., L.; (US).
MANDA, Venkatesh, R.; (US).
BURNES, John; (US)
Agent: HAHN, Roger; Hahn & Voight PLLC 1012 14th Street, NW Suite 620 Washington, DC 20005 (US)
Priority Data:
61/446,995 25.02.2011 US
61/550,896 24.10.2011 US
61/511,509 25.07.2011 US
61/565,911 01.12.2011 US
Title (EN) THERAPY FOR KIDNEY DISEASE AND/OR HEART FAILURE
(FR) THÉRAPIE POUR NÉPHROPATHIE ET/OU INSUFFISANCE CARDIAQUE
Abstract: front page image
(EN)Medical systems and methods for treating kidney disease alone, heart failure alone, chronic kidney disease with concomitant heart failure, or cardiorenal syndrome are described. The systems and methods are based on delivery of a natriuretic peptide such as Vessel Dilator to a subject. Methods for increasing and maintaining peptide levels at a certain concentration include direct peptide delivery via either an external or implantable programmable pump.
(FR)L'invention concerne des systèmes médicaux et des méthodes médicales pour traiter une néphropathie seule, une insuffisance cardiaque seule, une néphropathie chronique avec insuffisance cardiaque concomitante, ou un syndrome cardiorénal. Les systèmes et méthodes sont fondés sur l'administration d'un peptide natriurétique de type vasodilatateur à un patient. Des méthodes pour augmenter et maintenir les niveaux de peptide à une certaine concentration consistent à administrer directement le peptide par une pompe programmable externe ou implantable.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)